Go to main navigation Go to main content Go to footnote

Completed projects

ADVANCE(CAT) - Accelerator for the development of advance therapies in Catalonia (Official Code: COMRDI15-1-0013)

Barcelona Macula Foundation (BMF)

Universitat de Barcelona (UB)

Ferrer Internacional (Ferrer)

Banc de Sang i Teixits (BST)

Fundació Leitat


Centre de Medicina Regenerativa de Barcelona (CMRB)

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Fundació Bosch i Gimpera (FBiG)

Fundació Institut d’Investigacions en Ciències de la Salut Germans  Trias i Pujol (IGTP)

View more

Eye-Risk - Exploring the combined role of genetic and non-genetic factors that lead to AMD: a system-level analysis of disease subgroups, risk factors and pathways

Eberhard-Karls-Universität Tübingen (EKUT)
Erasmus Universiteit RotAterdam (EUR)
Fundació Centre de Regulació Genòmica, Barcelona (CRG)
Stichting Katholieke Universiteit Nijmegen (RUNMC)
Université de Bordeaux, Bordeaux (UB)
University College London (UCL)
Barcelona Macula Foundation (BMF)
Pro Retina eV., Amberg (PROR)
AyoxxA GmbH, Köln (AYOX)
F. Hoffmann-La Roche, Basel (ROC)
Moorfields Eye Hospital NHS Foundation Trust

View more

PRO4VIP - Innovative procurement for visually impaired people

Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
Sara Bedin (SB)
Universitá di Salerno (US)
Istituto Regionale Rittmeyer per i Ciechi (RITT)
Regione Friuli Venezia Giulia (FVG)
Area Science Park (AREA)
European Blind Union (EBU)
BerufsföRderungswerk Düren (BFW)
Barcelona Macula Foundation (BMF)
Zentrum fur innovation und Technik in Norddrhein-Westfalen GMBH (ZENIT)
European Clinical Infraestructure Network (ECRIN)
UCLPartners (UCLP)

View more

The brighter study: a 24-month, phase iiib, openlabel, randomized, active-controlled, threearm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven pro re nata dosing regimen with 0.5- mg ranibizumab intravitreal injections applied as monotherapy or with adjunctive laser photocoagulation in comparison to laser photocoagulation in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (brvo)

Barcelona Macula Foundation
Institut de la Màcula i de la Retina
And 45 more clinical sites worldwide

View more

Research is the only solution for the future to fight against blindness

It is only with your help that we can fight against blindness